Regulatory T cells and proinflammatory cytokine pathways

Regulatory T cells (Tregs) and proinflammatory cytokine pathways constitute a fundamental regulatory axis of the immune system responsible for maintaining self-tolerance and controlling inflammation. Tregs, primarily identified by the expression of CD4, CD25, and the master transcription factor FOXP3, exert suppressive effects on various immune cells through direct contact and the secretion of anti-inflammatory cytokines like IL-10 and TGF-beta (Sakaguchi et al., 2008, Nature Reviews Immunology). These cells counteract proinflammatory cytokine pathways, such as those mediated by Tumor Necrosis Factor-alpha (TNF-alpha), Interleukin-6 (IL-6), and Interleukin-17 (IL-17), which drive the activation and recruitment of effector lymphocytes and myeloid cells (Dinarello, 2000, Chest). In autoimmune diseases and chronic inflammatory conditions, this balance is often disrupted, characterized by either a quantitative or qualitative deficiency in Tregs or an overproduction of proinflammatory mediators (Vignali et al., 2008, Nature Reviews Immunology). Conversely, in oncology, the recruitment of Tregs into the tumor microenvironment can suppress anti-tumor immunity, allowing for cancer progression and resistance to immunotherapy (Facciabene et al., 2012, Cancer Research). Therapeutic interventions targeting this axis include the use of monoclonal antibodies to neutralize specific cytokines, such as Adalimumab for TNF-alpha or Tocilizumab for IL-6 (Feldmann & Maini, 2003, Nature Medicine). Additionally, the administration of low-dose IL-2 (Aldesleukin) is being explored to selectively expand the Treg population in autoimmune contexts (Klatzmann & Abbas, 2015, Nature Reviews Immunology). Monitoring this axis often involves measuring FOXP3+ cell frequencies and circulating cytokine levels as biomarkers for disease activity and treatment response.

Other names

Treg-cytokine axisImmune suppressive networkInflammatory signaling pathwaysTreg/Effector T cell balance

Modulation of the balance between suppressive regulatory T cells and effector proinflammatory signaling through cytokine neutralization, Treg expansion, or inhibition of costimulatory pathways to restore immune homeostasis.